BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30721918)

  • 1. Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers.
    Rosqvist F; McNeil CA; Pramfalk C; Parry SA; Low WS; Cornfield T; Fielding BA; Hodson L
    Am J Clin Nutr; 2019 Feb; 109(2):260-268. PubMed ID: 30721918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
    Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
    Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding.
    Chong MF; Hodson L; Bickerton AS; Roberts R; Neville M; Karpe F; Frayn KN; Fielding BA
    Am J Clin Nutr; 2008 Apr; 87(4):817-23. PubMed ID: 18400702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients.
    Lawitz EJ; Li KW; Nyangau E; Field TJ; Chuang JC; Billin A; Wang L; Wang Y; Huss RS; Chung C; Subramanian GM; Myers RP; Hellerstein MK
    J Lipid Res; 2022 Sep; 63(9):100250. PubMed ID: 35835205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men.
    Pramfalk C; Pavlides M; Banerjee R; McNeil CA; Neubauer S; Karpe F; Hodson L
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4425-33. PubMed ID: 26414963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using total plasma triacylglycerol to assess hepatic
    Hodson L; Parry SA; Cornfield T; Charlton C; Low WS; Green CJ; Rosqvist F
    Ups J Med Sci; 2020 Aug; 125(3):211-216. PubMed ID: 32208800
    [No Abstract]   [Full Text] [Related]  

  • 7. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet.
    Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
    Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual sugar challenge test for lipogenic sensitivity to dietary fructose.
    Hudgins LC; Parker TS; Levine DM; Hellerstein MK
    J Clin Endocrinol Metab; 2011 Mar; 96(3):861-8. PubMed ID: 21252253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Fructose Feeding on Intestinal Triacylglycerol Production and De Novo Fatty Acid Synthesis in Humans.
    Steenson S; Shojaee-Moradie F; B Whyte M; G Jackson K; Lovegrove JA; A Fielding B; Umpleby AM
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32549314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans.
    Beysen C; Ruddy M; Stoch A; Mixson L; Rosko K; Riiff T; Turner SM; Hellerstein MK; Murphy EJ
    Am J Physiol Endocrinol Metab; 2018 Jul; 315(1):E126-E132. PubMed ID: 29558206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins.
    Matikainen N; Adiels M; Söderlund S; Stennabb S; Ahola T; Hakkarainen A; Borén J; Taskinen MR
    Obesity (Silver Spring); 2014 Aug; 22(8):1854-9. PubMed ID: 24890344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study.
    Jacobs S; Jäger S; Jansen E; Peter A; Stefan N; Boeing H; Schulze MB; Kröger J
    PLoS One; 2015; 10(5):e0127368. PubMed ID: 25984792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans.
    Vedala A; Wang W; Neese RA; Christiansen MP; Hellerstein MK
    J Lipid Res; 2006 Nov; 47(11):2562-74. PubMed ID: 16929033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort.
    Zhu Y; Vogelpohl FA; Heiner-Fokkema MR; Pranger IG; Minović I; Navis GJ; Bakker SJL; Riphagen IJ
    J Clin Lipidol; 2022; 16(5):658-666. PubMed ID: 35909048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
    Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
    Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
    J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactation alters the relationship between liver lipid synthesis and hepatic fat stores in the postpartum period.
    Ramos-Roman MA; Syed-Abdul MM; Casey BM; Alger JR; Liu YL; Parks EJ
    J Lipid Res; 2022 Nov; 63(11):100288. PubMed ID: 36162520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32188593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios.
    Peter A; Cegan A; Wagner S; Lehmann R; Stefan N; Königsrainer A; Königsrainer I; Häring HU; Schleicher E
    Clin Chem; 2009 Dec; 55(12):2113-20. PubMed ID: 19850634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.